Literature DB >> 16735679

Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease.

Tohru Kobayashi1, Yoshinari Inoue, Kazuo Takeuchi, Yasunori Okada, Kazushi Tamura, Takeshi Tomomasa, Tomio Kobayashi, Akihiro Morikawa.   

Abstract

BACKGROUND: In the present study, we developed models to predict unresponsiveness to intravenous immunoglobulin (IVIG) in Kawasaki disease (KD). METHODS AND
RESULTS: We reviewed clinical records of 546 consecutive KD patients (development dataset) and 204 subsequent KD patients (validation dataset). All received IVIG for treatment of KD. IVIG nonresponders were defined by fever persisting beyond 24 hours or recrudescent fever associated with KD symptoms after an afebrile period. A 7-variable logistic model was constructed, including day of illness at initial treatment, age in months, percentage of white blood cells representing neutrophils, platelet count, and serum aspartate aminotransferase, sodium, and C-reactive protein, which generated an area under the receiver-operating-characteristics curve of 0.84 and 0.90 for the development and validation datasets, respectively. Using both datasets, the 7 variables were used to generate a simple scoring model that gave an area under the receiver-operating-characteristics curve of 0.85. For a cutoff of 0.15 or more in the logistic regression model and 4 points or more in the simple scoring model, sensitivity and specificity were 86% and 67% in the logistic model and 86% and 68% in the simple scoring model. The kappa statistic is 0.67, indicating good agreement between the logistic and simple scoring models.
CONCLUSIONS: Our predictive models showed high sensitivity and specificity in identifying IVIG nonresponders among KD patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16735679     DOI: 10.1161/CIRCULATIONAHA.105.592865

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  209 in total

Review 1.  Use of corticosteroids during acute phase of Kawasaki disease.

Authors:  Jeong Jin Yu
Journal:  World J Clin Pediatr       Date:  2015-11-08

2.  High Risk of Coronary Artery Aneurysms in Infants Younger than 6 Months of Age with Kawasaki Disease.

Authors:  Andrea P Salgado; Negar Ashouri; Erika K Berry; Xiaoying Sun; Sonia Jain; Jane C Burns; Adriana H Tremoulet
Journal:  J Pediatr       Date:  2017-04-10       Impact factor: 4.406

Review 3.  Kawasaki Disease update.

Authors:  Jane C Burns
Journal:  Indian J Pediatr       Date:  2009-04-18       Impact factor: 1.967

4.  Atypical Kawasaki disease.

Authors:  Vishal Puri; Madhuri Kanitkar
Journal:  Indian J Pediatr       Date:  2012-05-18       Impact factor: 1.967

5.  Evaluation of echogenicity of the heart in Kawasaki disease.

Authors:  Hazumu Nagata; Kenichiro Yamamura; Kiyoshi Uike; Yasutaka Nakashima; Yuichiro Hirata; Eiji Morihana; Yumi Mizuno; Shiro Ishikawa; Toshiro Hara
Journal:  Eur J Pediatr       Date:  2014-08       Impact factor: 3.183

6.  Evolution of laboratory values in patients with Kawasaki disease.

Authors:  Adriana H Tremoulet; Sonia Jain; Divya Chandrasekar; Xiaoying Sun; Yuichiro Sato; Jane C Burns
Journal:  Pediatr Infect Dis J       Date:  2011-12       Impact factor: 2.129

7.  Regulation of oxidative stress in patients with Kawasaki disease.

Authors:  Kaori Sekine; Hiroyuki Mochizuki; Yoshinari Inoue; Tohru Kobayashi; Eisuke Suganuma; Shinichi Matsuda; Hirokazu Arakawa
Journal:  Inflammation       Date:  2012-06       Impact factor: 4.092

8.  Analysis of biomarker serum levels in IVIG and infliximab refractory Kawasaki disease patients.

Authors:  Akira Hachiya; Norimoto Kobayashi; Satoshi Matsuzaki; Yusuke Takeuchi; Yohei Akazawa; Tomonari Shigemura; Noriko Motoki; Junya Masumoto; Kazunaga Agematsu
Journal:  Clin Rheumatol       Date:  2018-01-04       Impact factor: 2.980

9.  Delta-neutrophil index: a potential predictor of coronary artery involvement in Kawasaki disease by retrospective analysis.

Authors:  Sang Hun Lee; Kyung Ok Ko; Jae Woo Lim; Jung Min Yoon; Young Hwa Song; Jong Wook Lee; Eun Jung Cheon
Journal:  Rheumatol Int       Date:  2019-09-23       Impact factor: 2.631

Review 10.  Comparative effectiveness of intravenous immunoglobulin from different manufacturing processes on Kawasaki disease.

Authors:  Ming-Chih Lin
Journal:  World J Pediatr       Date:  2014-05-07       Impact factor: 2.764

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.